Pulmonary alveolar proteinosis (PAP) is a rare lung disease involving surfactant accumulation within the alveoli resulting from decreased clearance, rather than increased production. This condition can be congenital, secondary, or autoimmune. Autoimmune PAP is the most common pathophysiologic mechanism accounting for 90 percent of documented cases. This activity reviews the evaluation, treatment, and complications of pulmonary alveolar proteinosis and addresses the importance of an interprofessional team approach to its management.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/27999
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABTS - 1.5 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.5 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiothoracic, Clinical Pathology, Critical Care, General Pediatrics, General Surgery, General Thoracic, Hematology, Internal Medicine, Medical Oncology, Molecular Genetic Pathology, Pediatric Hematology-Oncology, Pediatric Pulmonology, Pulmonary Disease, Pulmonary, Mediastinum
Subscribe
Login
0 Comments
Oldest